MX2017013196A - Bioconjugados y usos de los mismos. - Google Patents

Bioconjugados y usos de los mismos.

Info

Publication number: MX2017013196A
Authority: MX; Mexico
Prior art keywords: binding unit; bioconjugates; peptide; vcam; selectin
Prior art date: 2015-04-17

Application number

MX2017013196A

Other languages

English (en)

Spanish (es)

Inventor

Eric Paderi John

Prestwich Glenn

Chen Julia

lloyd bartlett ii Rush

Original Assignee

Symic Ip Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-04-17

Filing date

2016-04-15

Publication date

2018-06-19

2016-04-15 Application filed by Symic Ip Llc filed Critical Symic Ip Llc

2018-06-19 Publication of MX2017013196A publication Critical patent/MX2017013196A/es

Links

108090000765 processed proteins & peptides Proteins 0.000 abstract 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
102000008186 Collagen Human genes 0.000 abstract 1
108010035532 Collagen Proteins 0.000 abstract 1
102000003800 Selectins Human genes 0.000 abstract 1
108090000184 Selectins Proteins 0.000 abstract 1
229920001436 collagen Polymers 0.000 abstract 1
150000004676 glycans Chemical class 0.000 abstract 1
229920002674 hyaluronan Polymers 0.000 abstract 1
229960003160 hyaluronic acid Drugs 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Cardiology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Obesity (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)

MX2017013196A 2015-04-17 2016-04-15 Bioconjugados y usos de los mismos. MX2017013196A (es)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201562149428P	2015-04-17	2015-04-17
US201562241057P	2015-10-13	2015-10-13
US201562244665P	2015-10-21	2015-10-21
PCT/US2016/027953 WO2016168743A1 (fr)	2015-04-17	2016-04-15	Bioconjugués et utilisations de ceux-ci

Publications (1)

Publication Number	Publication Date
MX2017013196A true MX2017013196A (es)	2018-06-19

Family

ID=55809257

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX2017013196A MX2017013196A (es)	2015-04-17	2016-04-15	Bioconjugados y usos de los mismos.

Country Status (18)

Country	Link
US (3)	US20160331841A1 (fr)
EP (1)	EP3283124B1 (fr)
JP (2)	JP2018513879A (fr)
KR (1)	KR102709827B1 (fr)
CN (1)	CN107771085B (fr)
AU (1)	AU2016248341B2 (fr)
BR (1)	BR112017021970A2 (fr)
CA (1)	CA2982680A1 (fr)
EA (1)	EA201792245A1 (fr)
ES (1)	ES2984980T3 (fr)
HK (1)	HK1251183A1 (fr)
IL (1)	IL254977B (fr)
MA (1)	MA44262A (fr)
MX (1)	MX2017013196A (fr)
PH (1)	PH12017501863A1 (fr)
SG (2)	SG11201708357QA (fr)
TW (1)	TW201718019A (fr)
WO (1)	WO2016168743A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUE044239T2 (hu)	2008-03-27	2019-10-28	Purdue Research Foundation	Kollagén-kötõ szintetikus peptidoglikánok, elõállításuk és alkalmazási eljárásaik
WO2014144969A1 (fr)	2013-03-15	2014-09-18	Purdue Research Foundation	Peptidoglycanes synthétiques de liaison à la matrice extracellulaire
CN105813661B (zh)	2013-12-10	2019-08-27	诺瓦普拉斯玛有限公司	用于操作植入物的容器、仪器和方法
WO2015164822A1 (fr)	2014-04-25	2015-10-29	Purdue Research Foundation	Peptidoglycanes synthétiques de liaison au collagène pour le traitement d'un dysfonctionnement endothélial
RU2016148469A (ru)	2014-05-12	2018-06-13	Пюрдью Рисёрч Фаундейшн	Конъюгаты пептидных лигандов селектина и icam/vcam
BR112017024018A2 (pt)	2015-05-11	2018-07-17	Nova Plasma Ltd	aparelho e método para manipulação de um implante
JP6876217B2 (ja) *	2017-05-19	2021-05-26	二村　芳弘	抗炎症作用を呈するペプチドグリカン誘導体
KR20200026263A (ko)	2017-07-07	2020-03-10	시믹 아이피, 엘엘씨	합성 생체접합체
AU2018298226B2 (en) *	2017-07-07	2024-06-06	Symic Ip, Llc	Biconjugates with chemically modified backbones
IL272671B2 (en)	2017-08-16	2024-01-01	Nova Plasma Ltd	Plasma treating an implant
WO2019075213A1 (fr) *	2017-10-11	2019-04-18	Northwestern University	Héparine conjuguée à des peptides se liant au collagène pour cibler des tissus biologiques et synthétiques
JP7457300B2 (ja) *	2018-08-29	2024-03-28	国立大学法人岡山大学	神経変性疾患の診断用ペプチドマーカー
CN109106940B (zh) *	2018-09-17	2021-08-27	大连医科大学附属第一医院	Iellqar作为预防和治疗动脉粥样硬化疾病药物中的应用
AU2020292274B2 (en)	2019-06-13	2024-05-23	Hollister Incorporated	Reusable urinary catheter products
AU2020304005B2 (en)	2019-06-25	2025-12-04	Hollister Incorporated	Reusable urinary catheter products
CN110755597B (zh) *	2019-10-24	2023-07-07	广州市希丽生物科技服务有限公司	用于预防和治疗类风湿性关节炎的外用药物组合物
US20240218016A1 (en) *	2019-12-02	2024-07-04	Shenzhen Institutes Of Advanced Technology	Peptides and their use in the treatment of inflammation
CN111701073A (zh) *	2020-06-01	2020-09-25	天津大学	一种基于胶原蛋白模拟肽改性透明质酸的关节注射制剂及其制备方法和应用
EP4630066A1 (fr) *	2022-12-08	2025-10-15	The General Hospital Corporation	Charge cornéenne

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE68926051T2 (de) *	1988-12-20	1996-08-29	Jolla Cancer Res Found	Polypeptid-polymer-konjugate mit wundheilender wirkung
US6719974B1 (en) *	1995-08-18	2004-04-13	Sloan-Kettering Institute For Cancer Research	Heat shock protein-based vaccines and immunotherapies
EP1570270A4 (fr) *	2002-11-15	2010-09-22	Univ Arizona	Bioconjugues therapeutiques
JP2008539169A (ja) *	2005-04-19	2008-11-13	イーライリリーアンドカンパニー	疾患における免疫学的介入のための一価および多価合成多糖類抗原
CN101252954A (zh) *	2005-06-30	2008-08-27	布里斯托尔-迈尔斯斯奎布药品公司	作为显像剂的酰肼偶联物
EP2207810A4 (fr) *	2007-10-12	2011-12-07	London Health Sciences Ct Res Inc	Compositions ayant une incidence sur une activité à médiation par l'acide hyaluronique
HUE044239T2 (hu) *	2008-03-27	2019-10-28	Purdue Research Foundation	Kollagén-kötõ szintetikus peptidoglikánok, elõállításuk és alkalmazási eljárásaik
WO2010129547A1 (fr) *	2009-05-04	2010-11-11	Purdue Research Foundation	Peptidoglycanes synthétiques se liant au collagène pour la cicatrisation
AU2011270862B2 (en) *	2010-06-23	2017-05-11	Purdue Research Foundation	Collagen-binding synthetic peptidoglycans for use in vascular intervention
WO2012112767A2 (fr) *	2011-02-16	2012-08-23	Purdue Research Foundation	Nanoparticules ciblées sur le collagène
US9217016B2 (en) *	2011-05-24	2015-12-22	Symic Ip, Llc	Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
US10766927B2 (en) *	2012-11-25	2020-09-08	The Regents Of The University Of California	Peptides that stimulate subcutaneous adipogenesis
WO2014144969A1 (fr) *	2013-03-15	2014-09-18	Purdue Research Foundation	Peptidoglycanes synthétiques de liaison à la matrice extracellulaire

2016
- 2016-04-15 BR BR112017021970A patent/BR112017021970A2/pt not_active IP Right Cessation
- 2016-04-15 AU AU2016248341A patent/AU2016248341B2/en not_active Ceased
- 2016-04-15 SG SG11201708357QA patent/SG11201708357QA/en unknown
- 2016-04-15 ES ES16718838T patent/ES2984980T3/es active Active
- 2016-04-15 SG SG10201909629P patent/SG10201909629PA/en unknown
- 2016-04-15 CA CA2982680A patent/CA2982680A1/fr not_active Abandoned
- 2016-04-15 WO PCT/US2016/027953 patent/WO2016168743A1/fr not_active Ceased
- 2016-04-15 HK HK18110765.2A patent/HK1251183A1/zh unknown
- 2016-04-15 US US15/130,821 patent/US20160331841A1/en not_active Abandoned
- 2016-04-15 EP EP16718838.2A patent/EP3283124B1/fr active Active
- 2016-04-15 EA EA201792245A patent/EA201792245A1/ru unknown
- 2016-04-15 MX MX2017013196A patent/MX2017013196A/es unknown
- 2016-04-15 CN CN201680033519.7A patent/CN107771085B/zh active Active
- 2016-04-15 MA MA044262A patent/MA44262A/fr unknown
- 2016-04-15 KR KR1020177032910A patent/KR102709827B1/ko active Active
- 2016-04-15 JP JP2018506084A patent/JP2018513879A/ja not_active Withdrawn
- 2016-04-18 TW TW105112035A patent/TW201718019A/zh unknown
2017
- 2017-10-10 IL IL254977A patent/IL254977B/en active IP Right Grant
- 2017-10-11 PH PH12017501863A patent/PH12017501863A1/en unknown
2019
- 2019-04-19 US US16/389,384 patent/US20200078469A1/en not_active Abandoned
2020
- 2020-11-27 JP JP2020196683A patent/JP7289036B2/ja active Active
2022
- 2022-03-14 US US17/694,513 patent/US20220313830A1/en not_active Abandoned

Also Published As

Publication number	Publication date
MA44262A (fr)	2021-03-24
US20200078469A1 (en)	2020-03-12
KR102709827B1 (ko)	2024-09-24
SG10201909629PA (en)	2019-11-28
US20220313830A1 (en)	2022-10-06
EA201792245A1 (ru)	2018-07-31
BR112017021970A2 (pt)	2018-07-10
EP3283124B1 (fr)	2024-04-24
JP2018513879A (ja)	2018-05-31
CN107771085B (zh)	2024-09-03
AU2016248341B2 (en)	2021-08-19
IL254977A (en)	2019-08-29
PH12017501863A1 (en)	2018-03-05
CN107771085A (zh)	2018-03-06
EP3283124A1 (fr)	2018-02-21
TW201718019A (zh)	2017-06-01
SG11201708357QA (en)	2017-11-29
HK1251183A1 (zh)	2019-01-25
ES2984980T3 (es)	2024-10-31
US20160331841A1 (en)	2016-11-17
CA2982680A1 (fr)	2016-10-20
AU2016248341A1 (en)	2017-11-30
JP2021042238A (ja)	2021-03-18
WO2016168743A1 (fr)	2016-10-20
IL254977B (en)	2021-03-25
JP7289036B2 (ja)	2023-06-09
KR20180016988A (ko)	2018-02-20

Publication	Publication Date	Title
PH12017501863A1 (en)	2018-03-05	Bioconjugates and uses thereof
SG10201803042PA (en)	2018-06-28	Anti-tim-3 antibodies
MY191581A (en)	2022-06-30	Anti-pd-1 antibodies
SG10201909805XA (en)	2019-11-28	Surface modified polymer compositions
MX2022015755A (es)	2023-01-19	Profarmacos de hormona paratiroidea (pth).
PH12017502180A1 (en)	2018-05-28	Tau-binding antibodies
IL261046A (en)	2019-02-28	Transduced 3,2,1-triazoles as selective nmda modulators for nr2b
EP4541424A3 (fr)	2025-07-02	Anticorps immunomodulateurs
MX2019007021A (es)	2019-10-21	Anticuerpos il-11ra.
MX2017004838A (es)	2017-10-16	Composiciones de interleucina-15 y usos de estas.
MX374635B (es)	2025-03-06	Nuevos peptidos inmunogenos.
MX2018005399A (es)	2018-06-06	Nuevo polipeptido con afinidad por pd-l1.
PH12017502207B1 (en)	2022-08-10	Tau-binding antibodies
CY1124425T1 (el)	2022-07-22	Συνθεσεις οι οποιες περιλαμβανουν συζευγματα φαρμακου αντισωματος-δουοκαρμυκινης
MX2019007152A (es)	2019-10-14	Peptido novedoso.
MX2022011695A (es)	2022-10-07	Compuestos para dispositivos opticamente activos.
GB2568181A (en)	2019-05-08	Wheat
EP4218790A8 (fr)	2023-10-04	Modulateurs de l'activité du complément
MX2023006458A (es)	2023-06-14	Oligosacaridos inmunomoduladores.
EP4331622A3 (fr)	2024-08-07	Peptides de liaison à l'intégrine et leurs utilisations
MX2017010883A (es)	2017-12-07	Composicion para el tratamiento de la infertilidad.
MX2017008390A (es)	2018-09-10	Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
PH12017502028A1 (en)	2018-04-02	Vortioxetine pyroglutamate
MY209140A (en)	2025-06-24	Novel peptide
WO2015139020A3 (fr)	2015-12-23	Compositions vaccinales et méthodes pour rétablir la fonction de la voie nkg2d contre les cancers